ScreenerHero

CSBR Champions Oncology, Inc.

NAS · US · Healthcare · Biotechnology · championsoncology.com
4.880USD-2.59%Mkt Cap: 67.92M $P/E: —

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implant…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap67.92M USD
Enterprise Value76.91M USD
Revenue (TTM)60.66M USD
Gross Profit28.52M USD
Net Income (TTM)-1.18M USD
Revenue/Share4.38 USD
Last Price4.880 USD
Fiscal Year EndApr 2026
MR QuarterJul 2026
Employees214
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)50.10
PEG—
EV/EBITDA191.32
EV/Revenue1.27
P/S1.15
P/B17.89
EPS (TTM)-0.07
EPS (Forward)0.10
52W Range
4.5908% of range8.310
52W High8.310 USD
52W Low4.590 USD
Profitability
Gross Margin48.00%
Oper. Margin-2.69%
EBITDA Margin0.66%
Profit Margin-1.98%
ROE-29.83%
ROA-4.35%
Growth
Revenue Growth8.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.47M USD
CapEx (TTM)564.00K USD
FCF Margin-9.05%
FCF Yield-8.08%
Net Debt6.61M USD
Net Debt/EBITDA16.45
Balance Sheet
Debt/Equity1.15
Current Ratio1.03
Quick Ratio0.96
Book Value/Sh0.28 USD
Cash/Share0.31 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateAug 12, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.13.92M
Float6.12M
Insiders26.33%
Institutions48.71%
Short Interest
Short Ratio7.1d
Short % Float1.00%
Short % Out.0.49%
Shares Short68.46K
Short (prev mo.)74.00K
Technical
SMA 505.092 (-4.2%)
SMA 2005.934 (-17.8%)
Beta0.44
S&P 52W Chg16.45%
Avg Vol (30d)11.89K
Avg Vol (10d)10.18K
Technical Indicators
RSI (14)43.4
MACD-0.0781
MACD Signal-0.0848
MACD Hist.+0.0067
BB Upper5.289 USD
BB Middle5.012 USD
BB Lower4.735 USD
BB Width11.05%
ATR (14)0.2356 USD
Vol Ratio (20d)2.06x